Statistics for Castle Biosciences (id:6515 CSTL)
Valuation metrics
Market cap
750.32M
Enterprise value
505.67M
Trailing P/E (ttm)
127.57
Forward P/E
-13.20
PEG ratio
-13.20
Price/Sales (ttm)
2.41
Price/Book (mrq)
1.70
Enterprise Value/Revenue
1.62
Enterprise Value/EBITDA
40.73
Overview
Shares outstanding
28.01M
Float
27.21M
Shares short
1.84M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
303.60K
Average volume (90 days)
Price summary
52-Week low
16.96
52-Week high
35.84
52-Week change
20.34%
Beta
3.00
50-Day moving average
31.13
200-Day moving average
25.59
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
1.95%
Operating margin
5.92%
Operational effectiveness
Return on assets
3.00%
Return on equity
1.47%
Income statement
Revenue (ttm)
11.34
Revenue per share (ttm)
11.34
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
174.81M
EBITDA
25.08M
Net income to common (ttm)
6.08M
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
39.50%
Balance sheet
Total cash (mrq)
279.78M
Total cash per share (mrq)
9.99
Total debt (mrq)
26.74M
Total Debt/Equity (mrq)
6.06
Current ratio (mrq)
778.40%
Book value per share (mrq)
15.77
Cash flow
Cash flow statement
59.09M
Levered free cash flow (LFCF)
30.83M